A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers.

Clinical trial NCT02711345 · TERMINATED

Trial details

NCT number: NCT02711345
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Neoplasms Non-Small-Cell Lung Carcinoma Melanoma Other Solid Tumors

Start date: 2016-04-15
Primary completion: 2018-11-21
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.